—JBHT
— • —
$227.04
P/E
36.95
PEG
0.04
FCF Yield
—
Rev Growth YoY
-73.0% YoY
Gross Margin
1926.0%
Health Score
4/10
D/E Ratio
0.41
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers for this security were not supplied in the data payload, making it impossible to describe the company's business operations or industry positioning from the provided data alone. Based on the available metrics — a current price of $227.04, a P/E of 36.95x, and a Price/Sales of 1.8x — this appears to be a mid-to-large-priced equity, though the market capitalisation figure is absent, preventing a definitive cap-tier classification. Given the severe data gaps, this analysis is necessarily limited in scope.
Financial Health
**Score: 4/10** The balance sheet carries a manageable Debt/Equity ratio of 0.41x, which is conservative and a clear positive. However, the reported gross margin of 1,926% and net margin of 499% are statistically anomalous and likely reflect either a non-standard revenue recognition structure, a one-time adjustment, or data integrity issues — these figures cannot be treated as reliable indicators of operational health...
Risk Assessment
- **REVENUE COLLAPSE:** Revenue declined -73.0% year-over-year, signalling a dramatic loss of business scale or a structural change in how revenue is recognised. - **DATA INTEGRITY:** Gross margin of 1,926% and net margin of 499% are implausible for most business models and may indicate restated, non-recurring, or incorrectly reported figures. - **LIQUIDITY:** Current ratio of 0.83x is below 1.0x, meaning current liabilities exceed current assets — the company may face short-term funding pressure. - **MISSING CASH FLOW:** Free cash flow is unavailable, making it impossible to determine whether reported profits translate into real cash generation. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) is active, and MACD is bearish — price is trading below both key moving averages. ---...